UNSPSC 51121912: Acetyldigitoxin

This classification denotes a glycoside and antiarrhythmic agent with the molecular formula C43H66O14, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0ZV4Q4L2FU, chemically known as digitoxin, alpha-acetyl- but generally known as acetyldigitoxin, which bears US NIH Compound Identifier 68949. European Medicines Agency schedules Acetyldigitoxin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05230MIG.

UNSPSC 51121912 Acetyldigitoxin is a Commodity code that represents pharmaceutical products supplied to state and local healthcare and emergency services agencies. In recent activity, state and local governments are procuring advanced life support medications and generic multi-source pharmaceuticals through sealed competitive bids and cooperative purchasing agreements rather than acetyldigitoxin specifically. The City of Tampa's Fire Rescue Department, the Texas Health and Human Services Commission, and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) are soliciting pharmaceutical suppliers to stock emergency medications, prescription programs, and OTC products for use across state agencies, local health systems, and fire departments. Vendors supplying under pharmaceutical commodity codes must meet FDA compliance, cGMP certification, Drug Supply Chain Security Act (DSCSA) requirements, and maintain relationships with authorized wholesalers or direct supply channels. Products must carry minimum shelf life guarantees (typically six to twelve months from delivery), safety documentation including OSHA Safety Data Sheets, and expiration-date warranties. Issuing bodies include city procurement offices managing emergency medical supplies, state health agencies coordinating pharmacy benefit programs, and multi-state cooperative purchasing organizations coordinating shared procurement across member jurisdictions.

Geographic activity centers on Florida, Texas, and Minnesota, with MMCAP's cooperative structure extending participation to Oregon and other member states. Recent representative solicitations include the City of Tampa's IFB 26P00188 for advanced life support medications (Labetalol, Epinephrine, Adenosine, Diltiazem) with a response deadline of April 8, 2026, and an estimated contract value of $40,000, which includes a 5 percent bid discount for Small Local Business Enterprise participation; MMCAP's RFP S1070000015802 for generic multi-source pharmaceuticals and OTC products with a March 26, 2026 response deadline and effective contract date of July 1, 2026; and the Texas HHS Commission's RFI HHS0017013 exploring direct-to-manufacturer prescription programs. The source shows limited specific matching to the Acetyldigitoxin commodity itself; recent state and local pharmaceutical procurement focuses on high-volume emergency medications, generics, and OTC products distributed through established wholesaler networks and cooperative purchasing vehicles rather than specialty cardiac glycosides.